| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Crinetics Pharmaceuticals, Inc. (CRNX) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. CRNX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 426.8K | $15.99M | - | |
| Dir | 116.1K | $4.35M | - | |
| Other | 71.8K | $2.69M | - | |
| Other | 55.0K | $2.06M | - | |
| COO | 55.0K | $2.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 13, 2022 | Struthers Richard Scott54 | President &CEO | Sell | 138,643 | $26.83 | $3,719,625.48 | -5.5% | -26.4% | -40.2% | |
| Apr 5, 2022 | Struthers Richard Scott54 | President &CEO | Sell | 21,357 | $25.34 | $541,224.82 | -2.4% | -17.9% | -34.2% | |
| Apr 4, 2022 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 9,000 | $23.97 | $215,761.50 | -7.2% | -19.3% | -34.1% | |
| Apr 1, 2022 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 8,328 | $21.43 | $178,474.87 | -3.2% | -20.9% | -31.9% | |
| Mar 15, 2022 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,123 | $18.94 | $59,149.62 | -2.3% | -10.0% | -9.9% | |
| Mar 1, 2022 | Madan Ajay | Chief Development Officer | Sell | 9,000 | $19.88 | $178,920.00 | -4.8% | -14.4% | +0.4% | |
| Mar 1, 2022 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,123 | $19.73 | $61,616.79 | -2.2% | -14.4% | +0.4% | |
| Feb 15, 2022 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,123 | $18.64 | $58,212.72 | -2.5% | +2.8% | +1.2% | |
| Feb 7, 2022 | Madan Ajay | Chief Development Officer | Sell | 13,411 | $17.83 | $239,084.60 | -7.2% | -8.2% | +16.0% | |
| Feb 1, 2022 | Betz Stephen F.61 | Chief Scientific Officer | Sell | 3,123 | $18.79 | $58,681.17 | -2.4% | +7.6% | +6.2% |